Dale Bredesen MD: The End of Alzheimer's

Alzheimer's disease functions as a protective response to systemic insults—such as inflammation, toxins, and nutrient deficiencies—rather than a singular, inevitable pathology. This paradigm shift from viewing Alzheimer's as a monolithic disease to a complex network disorder allows for personalized, multi-factorial treatment protocols like RECODE. By identifying and addressing the root causes of cognitive decline, including insulin resistance, pathogens, and environmental toxins, patients can achieve significant improvements in cognitive function. Early detection through a "cognoscopy"—a comprehensive evaluation of physiological markers—is essential, as pathophysiological changes often precede clinical diagnosis by decades. Moving beyond 20th-century "one-size-fits-all" pharmaceutical approaches, this systems-based model emphasizes lifestyle interventions, such as the KetoFlex 12-3 diet, exercise, and sleep optimization, to reverse cognitive decline and reduce the global burden of neurodegenerative illness.